Pages that link to "Q36676024"

The following pages link to Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA. (Q36676024):

Displaying 25 items.

• Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders (Q21129476) (← links)
• Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model (Q30830269) (← links)
• Global DNA methylation in neonatal sepsis (Q33418422) (← links)
• Heterogeneity and individuality: microRNAs in mental disorders (Q34447816) (← links)
• Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults (Q35090701) (← links)
• Brain region-specific alterations in the gene expression of cytokines, immune cell markers and cholinergic system components during peripheral endotoxin-induced inflammation (Q35192822) (← links)
• Role for the M1 Muscarinic Acetylcholine Receptor in Top-Down Cognitive Processing Using a Touchscreen Visual Discrimination Task in Mice (Q36794968) (← links)
• Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations. (Q36799047) (← links)
• Transient activation of hedgehog pathway rescued irradiation-induced hyposalivation by preserving salivary stem/progenitor cells and parasympathetic innervation (Q37632842) (← links)
• Evidence for impaired glucose metabolism in the striatum, obtained postmortem, from some subjects with schizophrenia (Q37648316) (← links)
• Molecular cues for development and regeneration of salivary glands (Q38159936) (← links)
• MicroRNAs in neuronal communication. (Q38175350) (← links)
• Role of miR-107 and its signaling pathways in diseases (Q38193569) (← links)
• Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back. (Q38262765) (← links)
• Personalized genetics of the cholinergic blockade of neuroinflammation. (Q39192238) (← links)
• Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor (Q39227633) (← links)
• Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders (Q39284158) (← links)
• COMT genotype is associated with differential expression of muscarinic M1 receptors in human cortex (Q39939195) (← links)
• DNA methylation and transcriptional trajectories during human development and reprogramming of isogenic pluripotent stem cells. (Q42377248) (← links)
• Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256. (Q47393629) (← links)
• Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia (Q48001582) (← links)
• Dysregulation of miRNA and its potential therapeutic application in schizophrenia. (Q50419804) (← links)
• Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia. (Q52320951) (← links)
• Association of childhood traumatization and neuropsychiatric outcomes with altered plasma micro RNA-levels (Q91713299) (← links)
• Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings (Q92453407) (← links)